0001628280-20-009811.txt : 20200623 0001628280-20-009811.hdr.sgml : 20200623 20200623083145 ACCESSION NUMBER: 0001628280-20-009811 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20200623 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200623 DATE AS OF CHANGE: 20200623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 20980357 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 8-K 1 trxc-form8xk06232020of.htm 8-K Document
false0000876378 0000876378 2020-06-23 2020-06-23


    
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
June 23, 2020
Date of Report (date of earliest event reported)
_________________
TransEnterix, Inc.
(Exact name of Registrant as specified in its charter)
_________________
Delaware
 
0-19437
 
11-2962080
(State or other jurisdiction of incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification Number)

635 Davis Drive, Suite 300
Morrisville, North Carolina 27560
(Address of principal executive offices)
919-765-8400
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading symbol
 
Name of each exchange on which registered
Common Stock
$0.001 par value per share
 
TRXC
 
NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
    




Item 8.01    Other Events
On June 23, 2020, TransEnterix, Inc., a Delaware corporation, issued a press release that Sana Klinikum Offenbach has entered into an agreement to lease and utilize a Senhance® Surgical System, which will be the fourth hospital in Germany to provide Senhance to its patients.
A copy of the press release is filed herewith as Exhibit 99.1 and incorporated herein by reference.
Item 9.01    Financial Statements and Exhibits.
(d) Exhibits.
Exhibit   No.  
Description
Press Release dated June 23, 2020
104
Cover Page Interactive Data File (formatted in inline XBRL)





2



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
 
TransEnterix, Inc.
 
 
 
Date: June 23, 2020
 
 
 
/s/ Brett Farabaugh
 
 
 
 
Brett Farabaugh
 
 
 
 
Interim Chief Financial Officer


3
 EX-99.1 2 exhibit991-offenbach.htm EXHIBIT 99.1 Exhibit


Exhibit 99.1

TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--June 23, 2020-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Sana Klinikum Offenbach has entered into an agreement to lease and utilize a Senhance® Surgical System. Located in the city of Offenbach am Main, the hospital is located close to Frankfurt and serves patients in the large Rhine-Main region of Germany.
“We are pleased that Sana Klinikum Offenbach has chosen to initiate a Senhance Digital Laparoscopic program,” said Anthony Fernando, president and chief executive officer at TransEnterix. “Germany continues to be a compelling location to realize the potential of surgery with Senhance, and this hospital will be the fourth hospital in Germany that offers Senhance to their patients. The deep experience and advanced laparoscopic skills of many German surgeons and the need for enabling technology at a responsible cost make Senhance a good choice for hospitals seeking to build robotics and digital surgery into their minimally invasive surgical offering.”
The Senhance System is the first and only digital laparoscopic surgical platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including, 3 mm microlaparoscopic instruments, eye sensing camera control and reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy. The Senhance System is also the first machine-vision system in robotic surgery which is powered by the new intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery.
“Senhance technology is a welcome addition to how we offer our patients the least invasive and most effective surgical care possible,” said Prof. Dr. Michael Lein, Head of the Department of Urology at Sana Klinikum Offenbach. “We were particularly pleased at how this system adds digital assistance in precision, control and vision to the foundation of laparoscopy which our surgical teams already perform with excellent results. The unique ability for the robot to have sensing of haptics and measuring forces applied in surgery is very important. The Senhance also adds advanced technology while helping to minimize waste and costs to our health system, which is more important than ever before in meeting our obligation to the health of all the people in the community we serve.”

About TransEnterix




At TransEnterix, Inc., we are digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through a new category of care called Digital Laparoscopy. Digitizing the interface enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and allows us to address the current clinical, cognitive and economic shortcomings in surgery. The Senhance®ฏ Surgical System brings the benefits of Digital Laparoscopy to patients around the world while staying true to the principles of value-based healthcare. Learn more about Digital Laparoscopy with the Senhance Surgical System here: https://Senhance.com/. Now available for sale in the US, the EU, Japan, and select other countries. For a complete list of indications for use, please visit: https://www.transenterix.com/indications-for-use/.

About Sana Klinikum Offenbach
The Sana Klinikum Offenbach is an academic teaching hospital of the Johann Wolfgang Goethe-University Frankfurt and is one of the largest clinic facilities in the Rhine-Main region. As a maximum care hospital with over 900 planned beds, the clinic has 23 specialist clinics, 5 institutes and certified specialist centers as well as one of the largest emergency rooms in Hessen. Around 2,300 employees ensure that around 39,000 inpatients and 74,000 outpatients are optimally cared for every year with the latest medical diagnosis and therapy methods.
Forward-Looking Statements

This press release includes statements relating to the Senhance System and Sana Klinikum Offenbach initiating a program with the Senhance System. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether the deep experience and advanced laparoscopic skills of many German surgeons and the need for enabling technology at a responsible costs will make the Senhance System a good choice for hospitals seeking to build robotics and digital surgery into their minimally invasive surgical offering. For a discussion of the risks and uncertainties associated with TransEnterix's business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 16, 2020 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward looking statements, which are based on our expectations as of the date of this press release and speak only as of the origination date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Source: TransEnterix, Inc.




For TransEnterix, Inc.
Investor Contact:
Mark Klausner, +1 443-213-0501
invest@transenterix.com

or

Media Contact:
Terri Clevenger, +1 203-682-8297
terri.clevenger@icrinc.com


 EX-101.DEF 3 trxc-20200623_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.PRE 4 trxc-20200623_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 5 trxc-20200623.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 trxc-20200623_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.LAB 7 trxc-20200623_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover Page [Abstract] Cover Page [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag JSON 8 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "trxc-form8xk06232020of.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "trxc-20200623_cal.xml" ] }, "definitionLink": { "local": [ "trxc-20200623_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-eedm-def-2018-01-31.xml", "http://xbrl.fasb.org/srt/2018/elts/srt-eedm1-def-2018-01-31.xml" ] }, "inline": { "local": [ "trxc-form8xk06232020of.htm" ] }, "labelLink": { "local": [ "trxc-20200623_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "trxc-20200623_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "trxc-20200623.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-roles-2018-01-31.xsd", "http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "trxc", "nsuri": "http://transenterix.com/20200623", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "trxc-form8xk06232020of.htm", "contextRef": "D2020Q2Offenbach", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page", "role": "http://transenterix.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "trxc-form8xk06232020of.htm", "contextRef": "D2020Q2Offenbach", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://transenterix.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "trxc_CoverPageAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover Page [Abstract]", "label": "Cover Page [Abstract]" } } }, "localname": "CoverPageAbstract", "nsuri": "http://transenterix.com/20200623", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 9 trxc-form8xk06232020of_htm.xml IDEA: XBRL DOCUMENT 0000876378 2020-06-23 2020-06-23 false 0000876378 8-K 2020-06-23 TransEnterix, Inc. DE 0-19437 11-2962080 635 Davis Drive Suite 300 Morrisville NC 27560 919 765-8400 false false false false Common Stock$0.001 par value per share TRXC NYSEAMER false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover Page Sheet http://transenterix.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports trxc-form8xk06232020of.htm exhibit991-offenbach.htm trxc-20200623.xsd trxc-20200623_cal.xml trxc-20200623_def.xml trxc-20200623_lab.xml trxc-20200623_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true XML 14 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover Page
Jun. 23, 2020
Cover Page [Abstract]  
Document Type 8-K
Document Period End Date Jun. 23, 2020
Entity Registrant Name TransEnterix, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 0-19437
Entity Tax Identification Number 11-2962080
Entity Address, Address Line One 635 Davis Drive
Entity Address, Address Line Two Suite 300
Entity Address, City or Town Morrisville
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27560
City Area Code 919
Local Phone Number 765-8400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock$0.001 par value per share
Trading Symbol TRXC
Security Exchange Name NYSEAMER
Entity Emerging Growth Company false
Entity Central Index Key 0000876378
Amendment Flag false
ZIP 15 0001628280-20-009811-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-20-009811-xbrl.zip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end XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }